Connect with us

Hi, what are you looking for?

Jewish Business News


Israel’s Chief Scientist Signs R&D Agreement with India’s Punj Lloyd

Deal to enable integration of Israeli technology in infrastructure projects around the world

By Ronit Goodman /

Israel’s Chief Scientist, Avi Hasson, travelled to New Delhi this week to sign an R&D cooperation agreement with Punj Lloyd to enable the integration of Israeli technology in projects performed by the Indian infrastructure company around the world.

The agreement was formed within the corporation-plan framework of the Chief Scientist, which is designed to create a strategic and technological cooperation between Israeli companies and large international corporations. The program provides an available and convenient platform for Israeli companies, with government funding, to promote research and development activities with customers.

The Punj Lloyd agreement is the 24th signed under this platform and the second with an Indian company. Other agreements have been signed with companies such as IBM, Coca-Cola, Merck, Deutsche Telekom, General Electric, Intel and HP.

“It is the second agreement signed with a large Indian company in less than a year, ” Hasson said. “It reflects the increased efforts of the Office of the Chief Scientist to strengthen technological cooperation with Indian industry.”

Punj Lloyd Group is one of the largest conglomerates in India, with annual revenue of $2.1 billion. It provides planning, implementation and management of large-scale construction and infrastructure projects. The company operates in four main areas: energy (oil and gas); civil engineering; petrochemicals; and water sector.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.